Invivyd (IVVD) Gross Profit (2024 - 2026)
Invivyd's (IVVD) quarterly Gross Profit came in at $13.0 million in Q2 2026, up 17.21% on a YoY basis from $11.1 million in Q2 2025, and down 19.01% quarter-over-quarter from $16.1 million in Q4 2025.
Analysis
Invivyd (IVVD) Gross Profit (2024 - 2026) Analysis & Trends
Invivyd (IVVD) has reported Gross Profit for 3 consecutive years, with $13.0 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Gross Profit rose 17.21% year-over-year to $13.0 million; the trailing twelve-month figure through Jun 2026 stood at $52.2 million (up 20.99% YoY), and the FY2025 full-year result was $49.7 million, up 109.03% from the prior year.
- Gross Profit fell to $13.0 million in Q2 2026 per IVVD's latest filing, from $16.1 million in the prior quarter.
- Across five years, Gross Profit topped out at $16.1 million in Q4 2025 and bottomed at $2.2 million in Q2 2024.
- Historically, Gross Profit has averaged $10.8 million across 3 years, with a median of $11.6 million in 2025.
- The sharpest annual moves came in 2025 and 2026: Gross Profit soared 410.16% in 2025, then increased 17.21% in 2026.
- Over 3 years, Gross Profit stood at $13.1 million in 2024, then climbed by 22.69% to $16.1 million in 2025, then slipped by 19.01% to $13.0 million in 2026.
- According to Business Quant data, Gross Profit over the past three periods registered $13.0 million, $16.1 million, and $12.0 million for Q2 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 236.37 Bn | 222.38 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 187.38 Bn | 184.12 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 138.36 Bn | 130.51 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 85.09 Bn | 77.10 Bn | 3.93 Bn |
| 5 | Argenx Se | 63.93 Bn | 58.75 Bn | 1.37 Bn |
| 6 | Moderna | 58.07 Bn | 52.94 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 35.59 Bn | 32.28 Bn | 992.69 Mn |
| 8 | Biogen | 32.63 Bn | 31.34 Bn | 1.96 Bn |
| 9 | Insmed | 27.57 Bn | 26.41 Bn | 358.27 Mn |
| 10 | Invivyd | 244.65 Mn | 84.57 Mn | 13.01 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 13.01 Mn |
| Dec 31, 2025 | 16.07 Mn |
| Sep 30, 2025 | 12.04 Mn |
| Jun 30, 2025 | 11.10 Mn |
| Mar 31, 2025 | 10.47 Mn |
| Dec 31, 2024 | 13.10 Mn |
| Sep 30, 2024 | 8.49 Mn |
| Jun 30, 2024 | 2.18 Mn |